AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 173 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $342,000 | +108.5% | 22,574 | +3.0% | 0.00% | +100.0% |
| Q2 2022 | $164,000 | -14.1% | 21,923 | +4.3% | 0.00% | 0.0% |
| Q1 2022 | $191,000 | +20.9% | 21,017 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $158,000 | -40.2% | 22,496 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $264,000 | -30.5% | 23,170 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $380,000 | -0.5% | 23,721 | +10.9% | 0.00% | 0.0% |
| Q1 2021 | $382,000 | +32.6% | 21,381 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $288,000 | +11.6% | 21,324 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $258,000 | -22.1% | 21,936 | -2.2% | 0.00% | -50.0% |
| Q2 2020 | $331,000 | -1.8% | 22,435 | -10.2% | 0.00% | 0.0% |
| Q1 2020 | $337,000 | -47.3% | 24,990 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $639,000 | +24.8% | 26,432 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $512,000 | -35.4% | 26,655 | -0.7% | 0.00% | -33.3% |
| Q2 2019 | $793,000 | -26.4% | 26,841 | +18.3% | 0.00% | -25.0% |
| Q1 2019 | $1,078,000 | +27.6% | 22,685 | -3.1% | 0.00% | +33.3% |
| Q4 2018 | $845,000 | -41.8% | 23,419 | -0.8% | 0.00% | -40.0% |
| Q3 2018 | $1,453,000 | -7.2% | 23,601 | +1.8% | 0.01% | 0.0% |
| Q2 2018 | $1,565,000 | +32.6% | 23,175 | +6.5% | 0.01% | +25.0% |
| Q1 2018 | $1,180,000 | -11.5% | 21,753 | -2.5% | 0.00% | 0.0% |
| Q4 2017 | $1,334,000 | +26.1% | 22,322 | +2.6% | 0.00% | 0.0% |
| Q3 2017 | $1,058,000 | +6.9% | 21,765 | +15.5% | 0.00% | 0.0% |
| Q2 2017 | $990,000 | +25.0% | 18,837 | +7.9% | 0.00% | +33.3% |
| Q1 2017 | $792,000 | +51.1% | 17,463 | +26.1% | 0.00% | +50.0% |
| Q4 2016 | $524,000 | -99.9% | 13,848 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $524,020,000 | +114.8% | 13,885 | +0.2% | 0.00% | +100.0% |
| Q2 2016 | $244,006,000 | +57.4% | 13,864 | +8.5% | 0.00% | 0.0% |
| Q1 2016 | $155,000,000 | -47.5% | 12,782 | +5.5% | 0.00% | 0.0% |
| Q4 2015 | $295,000,000 | +136474.1% | 12,116 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $216,000 | -100.0% | 12,124 | -67.4% | 0.00% | -66.7% |
| Q2 2015 | $656,015,000 | +212.1% | 37,168 | +454.2% | 0.00% | +200.0% |
| Q1 2015 | $210,197,000 | +6.9% | 6,707 | -0.5% | 0.00% | 0.0% |
| Q4 2014 | $196,711,000 | +35.8% | 6,739 | -3.7% | 0.00% | 0.0% |
| Q3 2014 | $144,830,000 | -14.9% | 7,000 | +1.8% | 0.00% | 0.0% |
| Q2 2014 | $170,244,000 | +52.9% | 6,873 | +30.8% | 0.00% | 0.0% |
| Q1 2014 | $111,353,000 | +20.9% | 5,255 | +2.5% | 0.00% | – |
| Q4 2013 | $92,117,000 | – | 5,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |